Erythromycin Ethyl 400mg/5ml Susp
Overview
What is this medicine?
How to Use This Medicine
To ensure you get the most benefit from your medication, follow these steps:
Take your medication exactly as directed by your doctor.
Read all the information provided with your medication and follow the instructions carefully.
You can take your medication with or without food, unless your doctor specifies otherwise.
Before using the liquid form of this medication, shake the bottle well.
Measure liquid doses accurately using the measuring device provided with the medication. If one is not included, ask your pharmacist for a suitable measuring device.
Continuing Your Medication
Continue taking your medication as directed by your doctor or healthcare provider, even if you start feeling better.
Storing and Disposing of Your Medication
Some brands of this medication require refrigeration, while others should be stored at room temperature. If you're unsure, consult your pharmacist.
Check the expiration date or shelf life of your medication to determine how long it can be stored before disposal.
Keep all medications in a safe and secure location, out of reach of children and pets.
What to Do If You Miss a Dose
If you miss a dose, take it as soon as you remember. However, if it's close to the time for your next scheduled dose, skip the missed dose and resume your regular dosing schedule. Do not take two doses at the same time or take extra doses.
Lifestyle & Tips
- Take the medication exactly as prescribed, even if you start feeling better. Do not skip doses or stop early.
- Shake the suspension well before each use.
- Measure the dose accurately using a special measuring spoon or cup, not a household spoon.
- Erythromycin ethylsuccinate can be taken with or without food, but taking it with food may help reduce stomach upset.
- Avoid grapefruit juice while taking this medication, as it can increase the amount of erythromycin in your body.
- Stay hydrated, especially if experiencing diarrhea.
Available Forms & Alternatives
Available Strengths:
- Erythromycin Ophth Oint 3.5gm
- Erythromycin 2% Gel 60gm
- Erythromycin 2% Gel 30gm
- Erythromycin Ophth Oint 1gm Sgl/use
- Erythromycin 2% Topical Soln 60ml
- Erythromycin DR 250mg Capsules
- Erythromycin Ophth Oint 1gm Sgl/use
- Erythromycin Base 250mg Tablets
- Erythromycin Base 500mg Tablets
- Erythromycin Ethyl 400mg/5ml Susp
- Erythromycin Eth 400mg Tablets
- Erythromycin 250mg DR Tablets
- Erythromycin 333mg EC Tablets
- Erythromycin 500mg EC Tablets
Dosing & Administration
Adult Dosing
Condition-Specific Dosing:
Pediatric Dosing
Dose Adjustments
Renal Impairment:
Hepatic Impairment:
Pharmacology
Mechanism of Action
Pharmacokinetics
Absorption:
Distribution:
Elimination:
Pharmacodynamics
Safety & Warnings
Side Effects
Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor or seek medical attention immediately:
Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin (with or without fever)
+ Wheezing
+ Tightness in the chest or throat
+ Difficulty breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Signs of liver problems, including:
+ Dark urine
+ Fatigue
+ Decreased appetite
+ Upset stomach or stomach pain
+ Light-colored stools
+ Vomiting
+ Yellow skin or eyes
Signs of a severe skin reaction (Stevens-Johnson syndrome/toxic epidermal necrolysis), such as:
+ Red, swollen, blistered, or peeling skin (with or without fever)
+ Red or irritated eyes
+ Sores in the mouth, throat, nose, or eyes
Urination problems, including:
+ Inability to pass urine
+ Changes in urine output
Severe dizziness or fainting
Rapid heartbeat
Abnormal heartbeat (long QT on ECG), which can be life-threatening. This risk may be increased when taking other medications with this drug. Seek medical help immediately if you experience an irregular heartbeat.
Diarrhea, particularly a severe form called C. diff-associated diarrhea (CDAD), which can lead to life-threatening bowel problems. If you experience stomach pain, cramps, or loose, watery, or bloody stools, contact your doctor right away.
Hearing loss, which is rare but may be more likely if you have kidney problems or take high doses of this medication. If you experience hearing problems, such as hearing loss, contact your doctor immediately.
Other Possible Side Effects
Most people do not experience significant side effects, but some may occur. If you notice any of the following side effects or any other symptoms that bother you or do not go away, contact your doctor:
Diarrhea
Stomach pain
Upset stomach
Vomiting
Decreased appetite
This is not an exhaustive list of possible side effects. If you have questions or concerns, contact your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
Seek Immediate Medical Attention If You Experience:
- Severe or persistent diarrhea (especially if bloody or watery, which could indicate C. difficile infection)
- Yellowing of skin or eyes (jaundice), dark urine, pale stools, or severe stomach pain (signs of liver problems)
- New or worsening heart palpitations, dizziness, or fainting (signs of heart rhythm problems)
- Significant hearing loss or ringing in the ears
- Signs of a new infection (e.g., oral thrush, vaginal yeast infection)
- Signs of an allergic reaction (rash, itching, swelling of face/tongue/throat, severe dizziness, trouble breathing)
Before Using This Medicine
Any allergies you have, including allergies to this drug, its components, or other substances. Be sure to describe the allergic reaction and its symptoms.
Certain health conditions, such as:
+ Abnormal heartbeat patterns, including a prolonged QTc interval on an electrocardiogram (ECG)
+ Slow heartbeat
+ Low potassium or magnesium levels
Any medications you are currently taking, including prescription and over-the-counter (OTC) drugs, natural products, and vitamins. This is crucial because some medications, such as those used to treat mood disorders, abnormal heart rhythms, or migraine headaches, may interact with this drug and should not be taken concurrently.
It is important to note that this is not an exhaustive list of all potential interactions. Therefore, it is vital to discuss all your medications and health conditions with your doctor and pharmacist to ensure safe use.
To guarantee your safety, always consult with your doctor before:
Starting or stopping any medication
Changing the dosage of any medication
* Taking this medication with other drugs or substances
By providing your doctor and pharmacist with a comprehensive list of your medications and health conditions, you can help ensure that it is safe for you to take this medication.
Precautions & Cautions
It is crucial that you inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this drug.
If you are taking this medication long-term, your doctor may recommend regular blood tests to monitor your condition. Be sure to discuss this with your doctor.
This medication may interfere with certain laboratory tests. Therefore, it is essential to notify all your healthcare providers and laboratory personnel that you are taking this drug.
Do not take this medication for longer than prescribed, as this may increase the risk of a second infection.
If you are following a low-sodium or sodium-free diet, consult your doctor before taking this medication, as some products may contain sodium.
If you have myasthenia gravis, discuss your condition with your doctor. If your symptoms worsen, contact your doctor immediately. Additionally, be aware that myasthenia gravis symptoms, such as new or worsening muscle weakness, difficulty chewing or swallowing, breathing problems, droopy eyelids, or changes in vision (including blurred vision or double vision), can occur in people without a history of the condition. If you experience any of these symptoms, seek medical attention promptly.
If you are 65 years or older, use this medication with caution, as you may be more susceptible to side effects.
If you are pregnant, planning to become pregnant, or breastfeeding, consult your doctor to discuss the potential benefits and risks to you and your baby.
Special Considerations for Newborns
In newborns taking this medication, a severe stomach problem can occur. If your child vomits or becomes irritable during feeding, contact your doctor immediately.
Overdose Information
Overdose Symptoms:
- Severe nausea
- Vomiting
- Abdominal pain
- Diarrhea
- Hearing loss (reversible)
- Liver dysfunction
What to Do:
Seek immediate medical attention or call a Poison Control Center (1-800-222-1222). Treatment is supportive and symptomatic. Gastric lavage may be considered if ingestion is recent.
Drug Interactions
Contraindicated Interactions
- Pimozide
- Ergot alkaloids (e.g., ergotamine, dihydroergotamine)
- Colchicine (in patients with renal or hepatic impairment)
Major Interactions
- Statins (e.g., simvastatin, lovastatin, atorvastatin) - increased risk of myopathy/rhabdomyolysis
- Warfarin - increased INR and bleeding risk
- Carbamazepine - increased carbamazepine levels and toxicity
- Cyclosporine - increased cyclosporine levels and nephrotoxicity
- Digoxin - increased digoxin levels
- Theophylline - increased theophylline levels and toxicity
- QT-prolonging drugs (e.g., antiarrhythmics like quinidine, disopyramide; antipsychotics like thioridazine, ziprasidone; tricyclic antidepressants) - increased risk of QT prolongation and Torsades de Pointes
- Oral contraceptives - reduced efficacy of contraceptives (rare, but possible)
- Cisapride (removed from market in many countries due to cardiac risk)
- Domperidone
- Flibanserin
- Lurasidone
- Midazolam (oral)
- Triazolam
Moderate Interactions
- Phenytoin - altered phenytoin levels
- Valproic acid - altered valproic acid levels
- Corticosteroids - increased corticosteroid levels
- Sildenafil, Tadalafil, Vardenafil - increased PDE5 inhibitor levels
- Tacrolimus - increased tacrolimus levels
- Clindamycin, Lincomycin - potential antagonism (do not use concurrently)
- Chloramphenicol - potential antagonism (do not use concurrently)
- Grapefruit juice - may increase erythromycin levels
Minor Interactions
- Antacids (aluminum/magnesium hydroxide) - may reduce absorption of erythromycin base (less relevant for ethylsuccinate)
Monitoring
Baseline Monitoring
Rationale: To establish baseline and identify pre-existing hepatic impairment, especially for prolonged therapy or in patients with liver disease history.
Timing: Prior to initiating therapy if risk factors are present or for prolonged use.
Rationale: To assess baseline QT interval, especially in patients with pre-existing cardiac conditions, electrolyte imbalances, or concomitant use of other QT-prolonging drugs.
Timing: Prior to initiating therapy if risk factors for QT prolongation are present.
Routine Monitoring
Frequency: Daily during acute treatment, then as clinically indicated.
Target: Resolution of infection symptoms (e.g., fever, pain, inflammation)
Action Threshold: Lack of improvement or worsening symptoms may indicate treatment failure, resistance, or incorrect diagnosis.
Frequency: Periodically (e.g., weekly to bi-weekly) for prolonged therapy (over 10-14 days) or in patients with hepatic impairment.
Target: Within normal limits or stable for patient's baseline.
Action Threshold: Significant elevation (e.g., >3x ULN) of ALT/AST or bilirubin may require dose reduction or discontinuation.
Frequency: More frequently (e.g., daily to every few days) if co-administered with warfarin.
Target: Patient-specific therapeutic range.
Action Threshold: INR outside target range requires warfarin dose adjustment.
Frequency: As clinically indicated, especially in patients at risk for QT prolongation or severe diarrhea.
Target: Within normal limits.
Action Threshold: Hypokalemia or hypomagnesemia should be corrected to reduce risk of Torsades de Pointes.
Symptom Monitoring
- Gastrointestinal upset (nausea, vomiting, abdominal pain, diarrhea)
- Signs of hepatotoxicity (jaundice, dark urine, pale stools, persistent fatigue, severe abdominal pain)
- Cardiac symptoms (palpitations, dizziness, syncope, chest pain) - indicative of QT prolongation
- Hearing changes (tinnitus, temporary hearing loss, especially with high doses or renal/hepatic impairment)
- Signs of superinfection (new or worsening fever, oral thrush, vaginal yeast infection, severe diarrhea/pseudomembranous colitis)
- Allergic reactions (rash, itching, swelling, severe dizziness, trouble breathing)
Special Patient Groups
Pregnancy
Erythromycin is generally considered safe for use during pregnancy (Category B). It is often used as an alternative for penicillin-allergic pregnant women.
Trimester-Specific Risks:
Lactation
Erythromycin is excreted into breast milk in small amounts. It is generally considered compatible with breastfeeding (L2).
Pediatric Use
Commonly used in pediatric patients. Dosing is weight-based. Caution in neonates due to potential for infantile hypertrophic pyloric stenosis (IHPS), though the risk is low and more associated with erythromycin base. Monitor for GI side effects.
Geriatric Use
No specific dose adjustment is typically required based on age alone. However, geriatric patients may be more susceptible to adverse effects, particularly hearing loss and QT prolongation, especially if they have underlying renal or hepatic impairment, or are on concomitant medications. Monitor renal and hepatic function and cardiac status.
Clinical Information
Clinical Pearls
- Erythromycin ethylsuccinate is preferred over erythromycin base for oral administration due to better acid stability and absorption, especially when taken with food.
- It is a potent CYP3A4 inhibitor, leading to numerous significant drug interactions. Always review concomitant medications.
- Can cause gastrointestinal upset (nausea, vomiting, abdominal cramps, diarrhea) which is a common reason for non-compliance or discontinuation.
- Risk of QT prolongation and Torsades de Pointes, especially with higher doses, pre-existing cardiac conditions, electrolyte imbalances, or co-administration of other QT-prolonging drugs.
- Rarely, hepatotoxicity (cholestatic hepatitis) can occur, usually reversible upon discontinuation.
- Transient hearing loss has been reported, particularly with high doses or in patients with renal or hepatic impairment.
Alternative Therapies
- Azithromycin (another macrolide, longer half-life, less frequent dosing, fewer CYP interactions)
- Clarithromycin (another macrolide, similar spectrum, more potent CYP3A4 inhibitor than azithromycin)
- Amoxicillin (for susceptible bacterial infections, especially respiratory)
- Doxycycline (for atypical pneumonia, chlamydia, skin infections)
- Levofloxacin/Moxifloxacin (fluoroquinolones, broader spectrum, reserved for specific indications due to side effects)